In the future, it may be possible to therapeutically influence the balance of STING signalling outputs, rather than STING activation per se, to promote the anti-tumour functions of DNA sensing in cancer, while limiting adverse effects on tumour progression. This evidence concerns the gene STING1 and neoplasm.